.jpg)
.png)
Summer 2014
This issue sponsored by the Pacific Lipid Association Featuring: "The PCSK9 Revolution: Hope or Hype? Latest Clinical Trial Results and Implications" and "Identifying Risk from Coronary Calcium Scoring" more
I am honored and truly humbled to have the opportunity to serve as the President of the National Lipid Association (NLA) during the 2014/2015 term. In just a few months as president, I’ve seen tremendous strides in the lipid community, which I only hope to continue during the remainder of my... more
.article-image{ display:inline-block; float:left; max-width:650px; padding-right:5px; margin-bottom:20px; } Caring for people is of the utmost importance to Dr. Wayne True, which is evident from his hectic daily schedule, volunteer mission work, and recent foray into the world of politics... more
The Foundation of the National Lipid Association (NLA) is constantly searching for new ways to reach members and educate the public about cholesterol disorders. And we’re always encouraged by the support we receive. This year we are excited to welcome a new member to the Foundation Board of... more
Dr. Rosenblit: I am honored to serve as President of the NLA’s Pacific Lipid Association (PLA) Chapter. The PLA membership and its board represent diversity of thought and expertise, but our unity lies in an enthusiasm for atherosclerosis prevention through lipid management. We have a... more
“I sometimes joke that if you come to our hospital missing a finger, no one will believe you until we get a CAT scan, an MRI and an orthopedic consult. We just don’t trust our senses.” ~ Dr. Abraham Verghese Recently, I had the opportunity to reread an old article on the... more
Clinical Feature: The PCSK9 Revolution: Hope or Hype? Latest Clinical Trial Results and Implications
.article-image{ display:inline-block; float:left; width: 550px; padding-right:5px; } In the late 1980s and in the 1990s, the emergence of the powerful statin drugs transformed treatment of dyslipidemia. Since then they have become the standard of care for managing this condition. Not since... more
.article-image{ display:inline-block; float:left; width: 550px; padding-right:5px; } John is a 55-year-old man who heard on the news that all patients over 50 years old should be taking a statin. He is generally healthy, without high cholesterol, but with a C-reactive protein (CRP) >2.... more
.article-image{ display:inline-block; float:left; width: 550px; padding-right:5px; } Atherosclerotic cardiovascular disease (ASCVD) is the major cause of morbidity, mortality, and medical costs in the U.S. While ASCVD is largely preventable with a healthy lifestyle and effective medical... more
.article-image{ display:inline-block; float:left; width: 550px; padding-right:5px; } The origins of the field of antisense technology date back to 1978, when Zamecnik — who 22 years earlier made the landmark discovery of transfer ribonucleic acid (tRNA) — and Stephenson first... more